Evidence map›Paper›PMID 31069755›Full record

ArticleNeurotoxicity research2019

In Vivo Evaluation of A1 Adenosine Agonists as Novel Anticonvulsant Medical Countermeasures to Nerve Agent Intoxication in a Rat Soman Seizure Model.

Thaddeus P Thomas, Amy Wegener, Tsung-Ming Shih

Abstract read
PubMed Publisher
In one paragraph

Article in Neurotoxicity research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Neurocognitive and neurobiological effects of low dose organophosphate exposure.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  2. Pharmacology of Adenosine ANeurotoxicity research · 2024
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Thaddeus P ThomasU.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, USA. thaddeus.p.thomas.civ@mail.mil.ORCID http://orcid.org/0000-0002-5817-9846
Amy WegenerU.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, USA.
Tsung-Ming ShihU.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, USA.
DEVCOM Army Research Laboratory · USUnited States Army · US

Funding

National Institutes of Health (NIH) AOD16024-001-00000/A120-B.P2016-02
6 · The paper itself

Abstract

Organophosphorus nerve agents (NAs) irreversibly inhibit acetylcholinesterase, which results in the accumulation of acetylcholine and widespread excitotoxic seizure activity. Because current medical countermeasures (anticholinergics, AChE reactivators, and benzodiazepines) lack sufficient anti-seizure efficacy when treatment is delayed, those intoxicated are at risk for severe brain damage or death if treatment is not immediately available. Toward developing a more effective anti-seizure treatment for NA intoxication, this study evaluated the efficacy of A1 adenosine (ADO) receptor (A1AR) agonists in a rat soman seizure model. One minute after exposure to soman (1.6 × LD

Indexed as

Medical CountermeasuresAdenosine A1 Receptor AgonistsAnimalsAnticonvulsantsDose-Response Relationship, DrugMaleNerve AgentsRatsRats, Sprague-DawleySeizuresSomanAdenosine A1 Receptor AgonistsAnticonvulsantsNerve AgentsSomanAdenosine agonistAnti-seizureGDNerve agentNeuroprotectionSoman

Identifiers

PMID31069755
OpenAlexW2901234143

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.